To understand the full metabolic impact of transitioning from suspension to a solid ECM environment, we collected BCR-DLBCL (U2932) cells for steady-state metabolomic analysis after growth in either suspension or ECM Matrigel, with or without MPC inhibition, for 4, 8, 12, or 24 hours. The gene discussed is BCR; the disease is diffuse large B-cell lymphoma.